Spiro imidazoline compounds
US6172097A · kind A · utility
1Cited by
2References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 17, 1999 |
| Grant date | Jan 9, 2001 |
| Priority date | — |
| Expiry date | Dec 17, 2019 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to a compound of formula (I): ##STR1## wherein: PA0 A represents an optionally substituted benzene ring, PA0 B represents an imidazoline ring of formula (Ia) or (Ib): ##STR2## and medicinal products containing the same/are useful in treating or in preventing depression, obesity, panic attacks, anxiety, obsessive-compulsive disorders, cognitive disorders, phobias, impulsive disorders associated with the abuse of drugs and withdrawal therefrom, sexual dysfunctions, and Parkinson's disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.